
Sign up to save your podcasts
Or


Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance. Related Content:
By JAMA Network4.4
470470 ratings
Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance. Related Content:

317 Listeners

699 Listeners

162 Listeners

256 Listeners

885 Listeners

295 Listeners

263 Listeners

3,339 Listeners

38 Listeners

21 Listeners

12 Listeners

11 Listeners

9 Listeners

16 Listeners

19 Listeners

5 Listeners

7 Listeners

1,151 Listeners

30 Listeners

194 Listeners

9 Listeners

92 Listeners

14 Listeners

5 Listeners

512 Listeners

5 Listeners

366 Listeners

427 Listeners

106 Listeners

18 Listeners

373 Listeners

3 Listeners

316 Listeners

271 Listeners